NDC 85534-0072-01 - Amoxicillin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85534-0072
- Requested NDC
- 85534-0072-01
- Package NDCs from labels
- 85534-0072-0, 85534-0072-1, 85534-0072-2, 85534-0072-01
- Manufacturer
- HAWAII REPACK, INC.
- Effective date
- 2026-07-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Amoxicillin - HAWAII REPACK, INC. | HAWAII REPACK, INC. | 2026-07-03 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amoxicillin | AMOXICILLIN | Preferred Pharmaceuticals Inc. | afef7c71-2d19-41ed-9213-b32ccc1bf1d3 | 2026-03-04 | Warnings, Adverse reactions | 313850 804826J2HU |
| Amoxicillin | AMOXICILLIN | Preferred Pharmaceuticals Inc. | 4b23e6f5-9287-4c01-b795-b8c538833039 | 2026-03-04 | Warnings, Adverse reactions | 308194 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 720ee5cf-1962-423b-ac81-6dd4f02b9206 | 2026-03-04 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Preferred Pharmaceuticals Inc. | c0e333d9-164d-4196-b5f5-929993d1c3c2 | 2026-03-04 | Warnings, Adverse reactions | 308189 804826J2HU |
| Sinus Defense 2.0 | LAC VACCINUM, SILICEA, ASPERGILLUS NIGER, BABESIA MICROTI, BORRELIA BURGDORFERI, CANDIDA ALBICANS, CANDIDA PARAPSILOSIS, CHLAMYDIA TRACHOMATIS, COLIBACILLINUM CUM NATRUM MURIATICUM, CYTOMEGALOVIRUS NOSODE, EHRLICHIA NOSODE, HERPES SIMPLEX I AND II NOSODE, HUMAN PAPILLOMA NOSODE, KLEBSIELLA PNEUMONIAE, MUCOR RACEMOSUS, MYCOBACTERIUM PARATUBERCULOSIS, PNEUMOCCOCCINUM, STAPHYLOCOCCUS AUREUS, STREPTOCOCCUS VIRIDANS, EPSTEIN-BARR VIRUS NOSODE, HERPES ZOSTER NOSODE | Micro Balance Health Products LLC | 560f84f6-2544-4ba8-8236-a95906eb7d97 | 2026-03-04 | Warnings | ETJ7Z6XBU4 |
| Amoxicillin | AMOXICILLIN | Preferred Phamraceuticals Inc. | 47424822-14a1-48e0-a62d-df34fe685726 | 2026-03-04 | Warnings, Adverse reactions | 308191 804826J2HU |
| Snore Control | BROMIUM, CHAMOMILLA, CINCHONA, CUPRUM METALLICUM, HELLEBORUS NIGER, HISTAMINUM HYDROCHLORICUM, HYDRASTIS CANADENSIS, KALI BICHROMICUM, LAUROCERASUS, NUX VOMICA, PHOSPHORICUM ACIDUM, RHUS TOX, SILICEA, STRAMONIUM, SULPHUR AND ZINCUM METALLICUM. | King Bio Inc. | 704bb574-6c54-49d1-bdae-81ffe0e79d10 | 2026-03-04 | Warnings | ETJ7Z6XBU4 |
| Amoxicillin | AMOXICILLIN | Preferred Pharmaceuticals Inc. | 573fcf4a-2b87-45d9-ac73-e1dec4fbc28b | 2026-03-04 | Warnings, Adverse reactions | 313850 308189 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals, Inc. | 22a387bd-92ce-4ebc-b475-20d7750a2507 | 2026-03-04 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Preferred Pharmaceuticals Inc. | 8dfbaa75-87ba-4a6b-a2db-176441a842af | 2026-03-04 | Warnings, Adverse reactions | 308189 804826J2HU |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 1b8a6312-ae47-45fb-ba5e-eedbc176afa0 | 2026-03-03 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Preferred Pharmaceuticals Inc. | d6a33b28-f520-4a4c-b553-0ebd00558345 | 2026-03-03 | Warnings, Adverse reactions | 308182 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | d23b6952-5e4c-4103-9fe0-a916b1e2e1b9 | 2026-03-03 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 618953a3-0256-42ce-9155-d35325f017aa | 2026-03-02 | Warnings, Adverse reactions | 804826J2HU |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 56fb634c-3725-4d0a-8f20-584652a1d99f | 2026-03-02 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Hikma Pharmaceuticals USA Inc. | 4fb7837e-964c-4d38-a3a5-b384b1bd6e08 | 2026-03-01 | Warnings, Adverse reactions | 308191 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 30446852-9a54-4d16-ba12-56ffd0149985 | 2026-02-27 | Warnings, Adverse reactions | 804826J2HU |
| 911 Adrenal Burnout and Fatigue | ACETICUM AC, ADRENALINUM, ADRENOCORTICOTROPHIN (30X), AESCULUS HIPPOCASTANUM, FLOS, ALFALFA, ALPHA-LIPOIC AC, AMBRA, ARG NIT, AVENA SATIVA, BRYONIA, CARBONEUM OXYGENISATUM, CARPINUS BETULUS, FLOS, DNA, FUMARICUM ACIDUM, GELSEMIUM SEMPERVIRENS, HEPAR SULPHURIS CALCAREUM, HYPOTHALAMUS, KALI PHOSPHORICUM, LACTICUM ACIDUM, LECITHIN, NATRUM MURIATICUM, OXALICUM ACIDUM, PHOSPHORICUM ACIDUM, PITUITARUM POSTERIUM, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SEPIA, SILICEA, SUCCINICUM ACIDUM AND THYROIDINUM. | King Bio Inc. | 21c6b6c1-e846-4f25-a1dc-02e79d1be756 | 2026-02-26 | Warnings | ETJ7Z6XBU4 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | PD-Rx Pharmaceuticals, Inc. | d213685c-5e67-4130-b00b-7626685dfa16 | 2026-02-26 | Warnings, Adverse reactions | 804826J2HU |
| Resilience | CEREBRUM SUIS, HYPOTHALAMUS SUIS, HYPOPHYSIS SUIS, SEROTONIN (HYDROCHLORIDE), NPY (NEUROPEPTIDE Y), CALCAREA CARBONICA, SILICEA, VERATRUM ALBUM, BLATTA AMERICANA, CACAO, DIOSPYROS KAKI, FORMICA RUFA, PALOONDO, SULPHUR, TAXUS BACCATA, TELA ARANEAE, SALIX VITELLINA, FLOS | Deseret Biologicals, Inc. | 3aa6c1e7-2bd9-4c2d-bfd4-63ffb7c62e9c | 2026-02-26 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.